Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 41-48 , February 2008

Surgical Management of Non–Small Cell Lung Cancer

  • Keri J. Wagner

      Affiliations

    • Corresponding Author InformationAddress correspondence to Keri J. Wagner, RN, NP, OCN®, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2007;57:43–66
  2. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2004/ (accessed April 3, 2007).
  3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479–485
  4. Azzoli CG. DX/RX: Lung cancer. Sudbury, MA: Jones and Bartlett Publishers; 2005;
  5. National Cancer Institute. Screening for lung cancer. Available at: http://www.cancer.gov/cancertopics/pdq/screening/lung/healthprofessional (accessed Nov 20, 2006).
  6. Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130:549–554
  7. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984;130:561–565
  8. Melamed MR, Flehinger BJ, Zamanet MB, et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984;86:44–53
  9. Ebeling K, Nischan P. Screening for lung cancer—results from a case-control study. Int J Cancer. 1987;40:141–144
  10. Bach PB, Niewoehner DE, Black WC. Screening for lung cancer. The guidelines. Chest. 2003;123(suppl):83S–88S
  11. Henschke CI, Yankelevitz DF, McCauley DI, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99–105
  12. Henschke CI, McCauley DI, Yanklevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–1771
  13. National Cancer Institute. National lung cancer screening trial. Available at: http://www.cancer.gov/nlst (accessed Nov 20, 2006).
  14. Ganti AK, Mulshine JL. Lung cancer screening: panacea or pipe dream?. Ann Oncol. 2005;16(suppl 2):ii215–ii219
  15. US Preventative Services Task Force . Lung cancer screening: recommendation statement. Ann Intern Med. 2004;140:738–739
  16. The NCCN Guideline: non-small cell lung cancer clinical practice guidelines in oncology (v.1.2007). National Comprehensive Cancer Network, Inc: 2006. Available at: http://www.nccn.org (accessed Apr 3, 2007).
  17. Martini N. Operable lung cancer. CA Cancer J Clin. 1993;43:201–214
  18. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  19. Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev. 2005;1:CD004699
  20. Grunwald DH. The role of surgery in non-small-cell lung cancers. Ann Oncol. 2005;16(suppl 2):ii220–ii222
  21. Rivera MP, Detterback F, Mehta AC. Diagnosis of cancer. The guidelines. Chest. 2003;123(suppl):129S–136S
  22. Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003;123(suppl):105S–114S
  23. Libby DM, Smith JP, Altorki NK, et al. Managing the small pulmonary nodule discovered by CT. Chest. 2004;125:1522–1529
  24. Grondin SC, Liptay MJ. Current concepts in the staging of non-small cell lung cancer. Surg Oncol. 2002;11:181–190
  25. Ashar BH, Hughes MT, Marinopoulos SS, et al. Current evidence for the use of emerging radiologic technologies for disease screening. Am J Manag Care. 2005;11:385–392
  26. Cerfolio RJ, Bryant AS, Ojha B, et al. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg. 2005;80:1207–1214
  27. Silvestri GA, Tanoue LT, Barker J, et al. The noninvasive staging of non-small cell lung cancer: The guidelines. Chest. 2003;123(suppl):147S–156S
  28. Stark P. Use of imaging studies in staging of non-small cell lung cancer. UpToDate. Available at: http://patients.uptodate.com/topic.asp?file=lung_ca/10419 (accessed June 22, 2007).
  29. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305–332
  30. Stark P. Computed tomographic and positron tomographic scanning of pulmonary nodules. UpToDate. Available at: http://patients.uptodate.com/topic.asp?file=pulm_img/2902 (accessed June 22, 2007).
  31. Stark P. Thoracic positron emission tomography. UpToDate. Available at: http://patients.uptodate.com/topic.asp?file=pulm_img/2094 (accessed June 22, 2007).
  32. Rusch VW. Mediastinoscopy: an endangered species?. J Clin Oncol. 2005;23:8283–8285
  33. Kirby TJ, Fell SC. Surgical techniques. In:  Pearson FG,  Hiebert CA,  Deslauriers J,  McKneally MF,  Ginsberg RJ,  Urschel HC editor. Thoracic surgery. New York, NY: Churchill Livingstone; 1995;p. 835–840
  34. De Leyn P, Lardinois D, VanSchil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32:1–8
  35. Ingle RJ. Lung cancers. In:  Yarbro CH,  Frogge MH,  Goodman M,  Groenwald SL editor. Cancer Nursing Principles and Practice. Ed 5. Sudbury, MA: Jones and Bartlett; 2000;p. 1298–1328
  36. Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75:56–63
  37. Agency for Healthcare Research and Quality. Treating tobacco use and dependence. Three brief clinical interventions. Available at http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.section.7741 (accessed Nov 20, 2006).
  38. Nia PS, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer. 2005;47:351–359
  39. Tsao AS, Liu D, Lee JJ, et al. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer. 2006;106:2428–2436
  40. Baser S, Shannon VR, Eapen GA, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest. 2006;130:1784–1790
  41. Waters PF. Surgical techniques pneumonectomy. In:  Pearson FG,  Hiebert CA,  Deslauriers J,  McKneally MF,  Ginsberg RJ,  Urschel HC editor. Thoracic surgery. New York, NY: Churchill Livingstone; 1995;p. 844–848
  42. Martini N, Ginsberg RJ. Lobectomy. In:  Pearson FG,  Hiebert CA,  Deslauriers J,  McKneally MF,  Ginsberg RJ,  Urschel HC editor. Thoracic surgery. New York, NY: Churchill Livingstone; 1995;p. 848–854
  43. Athanassiadi K, Kakaris S, Theakos N, et al. Muscle sparing versus posterolateral thoracotomy: a prospective study. Eur J Cardiothorac Surg. 2007;31:496–500
  44. Luh S, Liu H. Video-assisted thoracic surgery–the past, present status and the future. J Zhejiang Univ Sci. 2006;7:118–128
  45. Lewis RJ, Caccavale RJ, Sisler GE. Video assisted thoracic surgery. In:  Pearson FG,  Hiebert CA,  Deslauriers J,  McKneally MF,  Ginsberg RJ,  Urschel HC editor. Thoracic surgery. New York, NY: Churchill Livingstone; 1995;p. 917–929
  46. Van Schil P. Cost analysis of video-assisted thoracic surgery versus thoracotomy: critical review. Eur Respir J. 2003;22:735–738
  47. Bodner J, Wykypiel H, Wetcher G, et al. First experiences with the da Vinci operating robot in thoracic surgery. Eur J Cardiothorac Surg. 2004;25:844–851
  48. Park BJ, Flores RM, Rusch VW. Robotic assistance for video-assisted thoracic surgical lobectomy: technique and initial results. J Thorac Cardiovasc Surg. 2006;131:54–59
  49. Roberts JR, Pass HI. Lung cancer staging in non-small cell lung cancer including preoperative and intra-operative techniques. In:  Pass HI,  Carbone DP,  Johnson DH,  Minna JD,  Turrisi AT editor. Lung Cancer: Principles and Practice. 3rd Ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2005;p. 372–386
  50. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg. 2000;70:358–365
  51. Wu Y, Huang Z, Wang S, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1–6
  52. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ. 1995;311:899–909
  53. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351–360
  54. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589–2597
  55. Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, IIIA non-small-cell lung cancer. J Natl Cancer Inst. 2003;95:1453–1461
  56. Waller D, Peake RJ, Stephens NH, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the big lung trial. Eur J Cardiothorac Surg. 2004;26:173–182
  57. Le Chavalier T, Pignon JP, Bergman B, et al. Results of the randomized international adjuvant lung cancer trial (IALT): cisplatin-based chemotherapy (CT) vs. no CT in 1867 patients with resected non-small cell lung cancer (NSCLC). Lung Cancer. 2003;41(suppl 2):S3;PL-3
  58. Strauss GM, Herndon J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol. 2004;22(suppl 14S):621s;(abstr)
  59. Pisters KMW. Adjuvant chemotherapy for non-small cell lung cancer-the smoke clears. N Engl J Med. 2005;352:2640–2642
  60. Visbal AL, Leighl NB, Feld R, et al. Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest. 2005;128:2933–2943
  61. Wakelee H, Dubey S, Gandara D. Optimal adjuvant therapy for non-small cell lung cancer-how to handle stage I disease. Oncologist. 2007;12:331–337
  62. Amar D, Roistacher N, Rusch VW, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg. 2000;120:790–798
  63. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. J Am Coll Cardiol. 2002;39:542–558
  64. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. J Am Coll Cardiol. 2006;47:2343–2355
  65. Amar D. Postoperative atrial fibrillation. Heart Dis. 2002;4:117–123
  66. Lindhoff-Last E, Nakov R, Misselwitz F, et al. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol. 2002;118:1137–1142
  67. Bergqvist D. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol. 2007;95:167–174
  68. Nici L, Donner C, Woulters E, et al. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413

PII: S0749-2081(07)00140-4

doi: 10.1016/j.soncn.2007.11.011

Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 41-48 , February 2008

Article Tools

* Image Usage & Resolution